₹ 1,855.30
51.30 (2.84%)
A
Aurobindo Pharma
₹ 1,855.30
Aurobindo Pharma EPS Summary (consolidated)
The latest quarterly EPS of Aurobindo Pharma as of Q2 Sep 2026 stands at ₹19.57. This is a 9.57% growth quarter on quarter and 33.95% growth same quarter last year. The forecasted EPS for Q2 Sep 2026 was ₹19.43. It beat the estimate by ₹0.14. For the FY2026 the EPS of Aurobindo Pharma stands at ₹60.34. This is a 0.89% growth compared with FY2025.
Aurobindo Pharma EPS
EPS by Peers

S
Sun Pharmaceutical

D
Divis Laboratories

T
Torrent Pharmaceuticals

L
Laurus Labs

Z
Zydus Life Science
*Based on consolidated figures.

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App

